Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

Phase

Status

Unknown 6 Completed 6 Recruiting 4 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 5 Tongue Neoplasms 4 Head and Neck Neoplasms 4 Prostatic Neoplasms 2 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Squamous Cell 1 Mucositis 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Paclitaxel 20 Trastuzumab 17 Docetaxel 13 Cyclophosphamide 13 Capecitabine 10 Letrozole 9 Doxorubicin 9 exemestane 8 Radiotherapy 8 Fulvestrant 8 Lapatinib 7 Carboplatin 7 pembrolizumab 6 Goserelin 6 Anastrozole 6 palbociclib 5 eribulin 5 Therapeutics 5 Neoadjuvant Therapy 5 Chemotherapy, Adjuvant 5 Bevacizumab 5 Aromatase Inhibitors 5 tucatinib 4 abemaciclib 4 Vinorelbine 4 Taxes 4 Mastectomy, Segmental 4 Magnetic Resonance Spectroscopy 4 Exercise 4 Epirubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02079272 2015-04-06

REBECCA

Institut de Radioprotection et de Surete Nucleaire

Phase NA Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡